Preventing Meningococcal B Disease

Slides:

Advertisements

Similar presentations

Karen Broder, M.D. Epidemic Intelligence Service Officer

Advertisements

Contents  Describe epidemiology of meningococcal serogroups C disease  What, why and when are the changes happening  Which vaccines are recommended?

An Approach to Demonstration of Effectiveness

Meningococcemia: Epidemiology & Prevention Baylor College of Medicine Med-Peds Continuity Clinic Anoop Agrawal, M.D.

Epidemic cerebrospinal meningitis ----meningococcal meningitis.

ACIP Meeting Update November 4 th

Meningitis Created By: VSU Student Health Center Nursing Staff.

Adult Immunization 2010 Meningococcal Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.

What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.

1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.

Infectious Disease Modelling: challenges for policy makers Dr Mary Ramsay Head of Immunisation Public Health England.

1 Universal Immunization Against Rare Diseases  How much is a child’s life worth?  The individual vs society.

MENINGOCOCCAL DISEASE & PREVENTION Dr Deb Wilson Consultant in Communicable Disease Control 2001.

Bacterial Meningitis By Dana Burkart.

Meningitis. What is Meningitis? Inflammation of the tissues that cover the brain and spinal cord Organisms such as bacteria or viruses can infect the.

Meningococcal Meningitis in Africa: Overview Response strategies and Current challenges Eric Bertherat.

Meningococcal Meningitis Bacteria infection that causes inflammation of the spinal cord and brain. Bacteria infection that causes inflammation of the spinal.

Central Nervous System Infections. RABIES.

State Affiliate Challenge 1 South Dakota School Nurses Association Florida Association of School Nurses Delaware School Nurse Association.

Meningococcal Vaccine to Protect Against Meningitis What is Meningitis? Bacteria infection that causes inflammation of the spinal cord and brain. Bacteria.

Treat with confidence. Trusted answers from the American Academy of Pediatrics. The 2015 Childhood Immunization Schedule H. Cody Meissner, MD, FAAP Floating.

Meningococcal Disease and Meningococcal Vaccines

American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:

 Carolyn A. Parry, MPH CDC Public Health Advisor Montana Immunization Program 2016 Regional Immunization Workshops.

Meningococcal Disease and Meningococcal Conjugate Vaccine National Immunization Conference March 7, 2007.

Date of download: 6/21/2016 From: Recommended Adult Immunization Schedule: United States, October 2007–September 2008(1) Ann Intern Med. 2007;147(10):

Tips and Tricks: Child/Adolescent Immunization Schedule Candice Robinson, MD, MPH Medical officer March 16, 2016 National Center for Immunization & Respiratory.

Chapter 28 Meningococcal Disease. Epidemiology – U.S. Each year 1,400-3,000 cases of meningococcal disease (MD) in the US per 100,000 population.

Vaccine Update 2016 Kathryn Moffett, MD. Serogroup B Meningococcal Vaccine (Men B)

What is meningococcal disease?  Adolescents and young adults are at increased risk of meningococcal disease, often referred to as meningitis, a serious.

Adolescent Immunization Trivia

Meningococcal Vaccination

Adolescent Immunization Trivia

MenACWY – new immunisation programme? What’s new?

Changes to the 2016 Childhood and Adolescent Immunization Schedule

Kaity Zuerblis Lottie Segal Miguel BRiones

Nicki Banyard South London Health Protection Team

© I.M.Quizitor Pediatrics Date.

New Vaccines for Meningococcal Disease

2015 CSTE Annual Conference

Immunization of travelers against japanese encephalitis Dr Catherine Goujon Centre médical de.

Back to School 2013: An Immunization Checklist

An Update on Meningococcal Disease Dr Suzanne Cotter

Healthcare Strategies for HIV-Positive Girls and Women: Can We Do Better?

Dengue Prevention in Asia

Meningococcal Disease: Optimizing Protection in Adolescents

Global Update on Varicella: Protecting Against an Old Enemy

Meningococcal disease/vaccination update Ray Borrow

Immunization Against Varicella:

The State of Pneumococcal Disease Prevention

Meningococcal Meningitis

Immunization FaQs 2018 Amy Bachyrycz.

Maternal Pertussis vaccination: Giving Newborns a head start

Meningococcal B Vaccination Implementing the ACIP Category B Recommendations.

Serogroup B Meningococcal Disease

Adolescent Immunization Trivia

Preventing HPV-related Disease: What Do the Latest Data Tell Us?

IBD Increases Risk for Vaccine-Preventable Diseases

Immunization Throughout the Life Course: What Is the Clinician's Role?

Student Affairs Committee

Reconciling Aging With HIV

Update on Shingles.

Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention.

Prioritizing Prevention of HPV-Related Disease

Contribution of Vaccines to Life-Course Event-Free Health

MenB Update: Communicating the Imperative With Parents

Chief, Meningitis and Vaccine Preventable Diseases Branch

Meningitis Created By: VSU Student Health Center Nursing Staff

Presentation transcript:

Preventing Meningococcal B Disease

Meningococcal Disease

Incidence of Meningococcal Disease High in Adolescents

Epidemiology and Burden of Meningococcal Disease in the United States

Highest Incidence of Meningococcal Disease in Infants < 1 Year: Serogroup B Predominates

Who’s at Risk?

Meningitis Belt in Sub-Saharan Africa Areas With Frequent Epidemics of Meningococcal Meningitis

Dr Effiong Shares His Personal Experience

Incidence of Meningococcal Disease: All Age Groups

The 5 Primary Serogroups of Neisseria meningitidis Bacteria in the United States

Incidence of Meningococcal Disease: Adolescents

Are Adolescents Entering College at Increased Risk?

Recent Meningococcal B Disease Outbreaks on US College Campuses

Meningococcal Vaccines Approved for Use in the United States

ACIP Recommendations

Category A Recommendations for A, C, W, Y (All Adolescents)

Meningococcal Vaccines: Category A Recommendations (High-Risk)

MenB Vaccines: Safety

Meningococcal Vaccine Dosing Schedules

Meningococcal Vaccines: Having the Conversation With Parents

Establish Consistent Vaccine Messages in Your Practice Setting

Important Points About the Second Dose of MenB

IAC Resources

Concluding Remarks

Abbreviations